The PPARγ1 ligand can induce G0/G1 phase arrest of human hepatoma cells, and phosphorylation of PPARγ1 can reduce its transcriptional activity and promote the proliferation of human fibrosarcoma cells [65,66]. Here, PPARG is linked to hepatocellular carcinoma.